These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia. Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302 [TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation. Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia. Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536 [TBL] [Abstract][Full Text] [Related]
6. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Drexler HG Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433 [TBL] [Abstract][Full Text] [Related]
7. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711 [TBL] [Abstract][Full Text] [Related]
8. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation. Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310 [TBL] [Abstract][Full Text] [Related]
9. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor. Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245 [TBL] [Abstract][Full Text] [Related]
10. [Activity of various hematopoietic growth factors on acute myeloblastic leukemia blasts]. Almeida J; del Cañizo MC; Vidriales B; Hernández MD; Galende J; San Miguel J Sangre (Barc); 1996 Feb; 41(1):3-8. PubMed ID: 8779032 [TBL] [Abstract][Full Text] [Related]
11. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis. Kerst JM; Slaper-Cortenbach IC; von dem Borne AE; van der Schoot CE; van Oers RH Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML). Wörmann B; Hiddemann W; Frisch J; Zühlsdorf M; Rottmann R; Boeckmann A; Reuter C; Freire EA; Innig G; Schulz G Behring Inst Mitt; 1991 Dec; (90):28-38. PubMed ID: 1801688 [TBL] [Abstract][Full Text] [Related]
13. In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells. Aglietta M; De Felice L; Stacchini A; Petti MC; Bianchi AC; Aloe Spiriti MA; Sanavio F; Apra F; Piacibello W; Stern AC Leukemia; 1991 Nov; 5(11):979-84. PubMed ID: 1961040 [TBL] [Abstract][Full Text] [Related]
14. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow. Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784 [TBL] [Abstract][Full Text] [Related]
15. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia. Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275 [TBL] [Abstract][Full Text] [Related]
16. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction. Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331 [TBL] [Abstract][Full Text] [Related]
17. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells. Murohashi I; Yoshida K; Kishimoto K; Takahashi T; Wakao D; Jinnai I; Yagasaki F; Kawai N; Suzuki T; Matsuda A; Hirashima K; Bessho M J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041 [TBL] [Abstract][Full Text] [Related]
18. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines. Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401 [TBL] [Abstract][Full Text] [Related]
19. TPA induces differentiation of purified human myeloblasts in the absence of proliferation. Griffin JD; Larcom P; Kufe DW Exp Hematol; 1985 Nov; 13(10):1025-32. PubMed ID: 3932087 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]